与瘦个体相比,肥胖个体的葡萄糖依赖性炎症反应与瘦个体相比
Martin H Lundqvist1, Maria J Pereira2, Jan W Eriksson
1Clinical Diabetology and Metabolism, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. martin.lundqvist@medsci.uu.se.
Endocrine
|July 3, 2023
概括
肥胖和胰岛素抵抗与炎症有关. 这项研究发现,血糖和胰岛素水平的急性变化抑制了炎症标志物,特别是在肥胖个体中,这表明这些变化不会加剧炎症.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 肥胖与慢性炎症有关,这是胰岛素抵抗和2型糖尿病的潜在驱动因素.
- 了解对葡萄糖和胰岛素波动的炎症反应对于代谢健康至关重要.
研究的目的:
- 研究肥胖个体对葡萄糖和胰岛素血清变异的炎症标志物反应的改变.
- 为了比较肥胖和瘦人之间的高胰岛素血症,低血糖和高血糖期间的炎症概况.
主要方法:
- 在使用近距离延伸测试的肥胖和瘦身个体的血样本中分析了92个炎症标志物.
- 利用高胰岛素-高血糖-低血糖和高血糖技术来诱导特定的代谢状态.
- 在禁食时收集的样本,在高胰岛素血糖-高血糖,低血糖和高血糖期间.
主要成果:
- 胰岛素高血压,低血糖和高血糖通常会抑制炎症标志物,在肥胖个体中观察到更明显的抑制.
- 特定的炎症标志物,如FGF-21,IL-6和IL-10,在不同的血糖/胰岛素状况下显示出明显的变化.
- 发现了身体质量指数 (BMI),HbA1c,M值以及各种炎症标志物的变化之间的相关性.
结论:
- 葡萄糖和胰岛素水平的急性变化导致炎症标志物的抑制,特别是在肥胖和胰岛素耐药的人群中.
- 这些发现表明,急性血糖或胰岛素挑战可能不会直接加剧导致胰岛素抵抗和失糖症的炎症途径.
相关概念视频
Obesity
544
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
544
Hormones Regulating Blood Glucose
3.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.6K
Hypoglycemia and Glucagon
305
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
305
Glucose Homeostasis: Regulation of Blood Glucose
1.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Inflammation
53.9K
Overview
53.9K


